Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
visuprime
- Development stage
- Unknown
- Lead developer
- Visufarma
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
VISUPRIME is a commercially available ophthalmic solution developed primarily as an antimicrobial eye drop for reducing conjunctival bacterial load. It has demonstrated broad-spectrum **antibacterial** activity against Gram-positive and Gram-negative bacteria, including *Staphylococcus aureus*, *Staphylococcus epidermidis*, *Pseudomonas aeruginosa*, *Escherichia coli*, and *Klebsiella pneumoniae*. Additionally, it exhibits **antiviral** activity, notably against herpes simplex virus 1 (HSV-1). Its mechanism is largely nonselective, providing empirical, broad-spectrum antimicrobial protection. VISUPRIME has been studied as prophylaxis in patients undergoing intravitreal anti-VEGF injections and cataract surgery to reduce the risk of ocular infections. The product is marketed and manufactured by VISUfarma SpA, an Italian ophthalmic pharmaceutical company[3][4][5].
- Brand names
- VISUPRIME
- Other names
- Visuprime eye drops
Beyond the preview
Go deeper on visuprime.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on visuprime.